share_log

Oppenheimer Maintains Outperform on Gilead Sciences, Maintains $105 Price Target

Moomoo 24/7 ·  Apr 19 10:57

Oppenheimer analyst Hartaj Singh maintains Gilead Sciences (NASDAQ:GILD) with a Outperform and maintains $105 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment